ZOTEPINE IN THE TREATMENT OF SCHIZOPHRENIC-PATIENTS WITH PREVAILINGLY NEGATIVE SYMPTOMS - A DOUBLE-BLIND TRIAL VS HALOPERIDOL

被引：80
|
作者：
BARNAS, C
STUPPACK, CH
MILLER, C
HARING, C
SPERNERUNTERWEGER, B
FLEISCHHACKER, WW
机构：
[1] Biological Psychiatry Research Unit, Department of Psychiatry, University of Innsbruck
来源：
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | 1992年 / 7卷 / 01期
关键词：
D O I：
10.1097/00004850-199200710-00003
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Zotepine, a neuroleptic agent with additional 5-HT2 blocking properties, was compared with haloperidol in the treatment of schizophrenic patients with predominantly negative symptoms using a double-blind design. During the investigation period zotepine treated patients showed significant improvements in all rating instruments whereas haloperidol treated patients did not. Patients in the zotepine group developed fewer clinical side effects. The results of the presented study confirm the positive impressions gained in earlier open trials with zotepine.
引用
收藏
页码：23 / 27
页数：5
相关论文
共 50 条
  • [41] DRUG TREATMENT OF ADOLESCENT TIQUEURS - A DOUBLE-BLIND TRIAL OF DIAZEPAM AND HALOPERIDOL
    CONNELL, PH
    CORBETT, JA
    HORNE, DJ
    MATHEWS, AM
    BRITISH JOURNAL OF PSYCHIATRY, 1967, 113 (497) : 375 - &
  • [42] A DOUBLE-BLIND STUDY OF SKF 14336 VS TRIFLUOPERAZINE IN SCHIZOPHRENIC PATIENTS
    FREEMAN, H
    OKTEM, N
    OKTEM, MR
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1968, 10 (10): : 537 - &
  • [43] Elementary cognitive subprocesses in a double-blind study of haloperidol and risperidone in subchronic schizophrenic patients
    Ulferts, J
    Hagenhoff, M
    Krieger, S
    Gallhofer, B
    PHARMACOPSYCHIATRY, 2003, 36 (05) : 269 - 269
  • [44] NEGATIVE SYMPTOMS AND COGNITIVE DEFICITS IN SCHIZOPHRENIC-PATIENTS - REPLY
    WALKER, E
    GREEN, M
    AMERICAN JOURNAL OF PSYCHIATRY, 1986, 143 (09): : 1197 - 1197
  • [45] EFFICACY AND SAFETY OF SERTINDOLE IN DOUBLE-BLIND, PLACEBO-CONTROLLED TRIALS OF SCHIZOPHRENIC-PATIENTS
    MARTIN, PT
    GREBB, JA
    SCHMITZ, PJ
    SEBREE, TB
    KASHKIN, KB
    SCHIZOPHRENIA RESEARCH, 1994, 11 (02) : 107 - 107
  • [46] DIALYSIS OF SCHIZOPHRENIC-PATIENTS - A DOUBLE-BLIND-STUDY
    DIAZBUXO, JA
    CAUDLE, JA
    CHANDLER, JT
    FARMER, CD
    HOLBROOK, WD
    AMERICAN JOURNAL OF PSYCHIATRY, 1980, 137 (10): : 1220 - 1222
  • [47] SENSORY INPUT DEFICITS AND NEGATIVE SYMPTOMS IN SCHIZOPHRENIC-PATIENTS
    BRAFF, DL
    AMERICAN JOURNAL OF PSYCHIATRY, 1989, 146 (08): : 1006 - 1011
  • [48] THE USE OF ANTIDEPRESSANTS FOR NEGATIVE SYMPTOMS IN A SUBSET OF SCHIZOPHRENIC-PATIENTS
    SIRIS, SG
    BERMANZOHN, PC
    GONZALEZ, A
    MASON, SE
    WHITE, CV
    SHUWALL, MA
    PSYCHOPHARMACOLOGY BULLETIN, 1991, 27 (03) : 331 - 335
  • [49] Escitalopram in the treatment of negative symptoms in chronic schizophrenia patients: A randomized double-blind placebo-controlled trial
    Iancu, I.
    Tchernihovsky, E.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 140 - 140
  • [50] Escitalopram in the treatment of negative symptoms in patients with chronic schizophrenia: A randomized double-blind placebo-controlled trial
    Iancu, Iulian
    Tschernihovsky, Eleonora
    Bodner, Ehud
    Piconne, Anna Sapir
    Lowengrub, Katherine
    PSYCHIATRY RESEARCH, 2010, 179 (01) : 19 - 23
12345